AGP Picks
View all

Healthy Living Europe
Provided by AGP

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 1, 2026

A Saudi Hospital Cut the Cost of CAR-T by 80 Percent
May 1, 2026

A Saudi Hospital Cut the Cost of CAR-T by 80 Percent

Indeterminate EIN Presswire
Animal Disinfectants Market Analysis Report 2026: Major Trends, Influencing Factors, and Forecast Overview
May 1, 2026

Animal Disinfectants Market Analysis Report 2026: Major Trends, Influencing Factors, and Forecast Overview

Indeterminate EIN Presswire
Comprehensive Report on the Research Antibodies and Reagents Market: Opportunities and Challenges
May 1, 2026

Comprehensive Report on the Research Antibodies and Reagents Market: Opportunities and Challenges

Indeterminate EIN Presswire
Artificial Intelligence (AI) Medical Scribe Software Market: Future Demand and Trends Analysis Analysis | 2030
May 1, 2026

Artificial Intelligence (AI) Medical Scribe Software Market: Future Demand and Trends Analysis Analysis | 2030

Indeterminate EIN Presswire
Plasma Protein Therapeutics Market to Reach USD $63.32 Billion by 2030 at 9.5% CAGR
May 1, 2026

Plasma Protein Therapeutics Market to Reach USD $63.32 Billion by 2030 at 9.5% CAGR

Indeterminate EIN Presswire
Human Serum Albumin Market Expanding With $8.08 Billion at 6.9% CAGR by 2030
May 1, 2026

Human Serum Albumin Market Expanding With $8.08 Billion at 6.9% CAGR by 2030

Indeterminate EIN Presswire
Comprehensive Report on the Enzyme Replacement Therapy Market: Opportunities and Challenges
May 1, 2026

Comprehensive Report on the Enzyme Replacement Therapy Market: Opportunities and Challenges

Indeterminate EIN Presswire
Chimeric Antibody Market to Reach USD $23.34 Billion by 2030 at 11.3% CAGR
May 1, 2026

Chimeric Antibody Market to Reach USD $23.34 Billion by 2030 at 11.3% CAGR

Indeterminate EIN Presswire
20/15 Visioneers Completes Acquisition of Paperless Lab Academy®, Expanding its Global Reach in R&D Thought Leadership
May 1, 2026

20/15 Visioneers Completes Acquisition of Paperless Lab Academy®, Expanding its Global Reach in R&D Thought Leadership

Indeterminate EIN Presswire
Enlighten Clinical Solutions Announces Launch of Clinical Trial Management System (CTMS) at Eyecelerator @ ARVO 2026
May 1, 2026

Enlighten Clinical Solutions Announces Launch of Clinical Trial Management System (CTMS) at Eyecelerator @ ARVO 2026

Indeterminate EIN Presswire
Pennant Acquires Senior Living Communities in Arizona and Wisconsin
May 1, 2026

Pennant Acquires Senior Living Communities in Arizona and Wisconsin

Indeterminate GlobeNewswire
Qué ocurre después del avance: En KFSH, la innovación se mide por la repetición
May 1, 2026

Qué ocurre después del avance: En KFSH, la innovación se mide por la repetición

Indeterminate GlobeNewswire
O Que Acontece Depois do Grande Avanço: No KFSH, a Inovação é Medida pela Repetição
May 1, 2026

O Que Acontece Depois do Grande Avanço: No KFSH, a Inovação é Medida pela Repetição

Indeterminate GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer
May 1, 2026

Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer

Indeterminate GlobeNewswire
Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort
May 1, 2026

Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

Indeterminate GlobeNewswire
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Refills GLP-1 Weight Loss Claims Evaluated: The Most Affordable Personalized Semaglutide & Tirzepatide GLP1 Program with Online Doctor Support
May 1, 2026

Refills GLP-1 Weight Loss Claims Evaluated: The Most Affordable Personalized Semaglutide & Tirzepatide GLP1 Program with Online Doctor Support

Indeterminate GlobeNewswire
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.